Tianjin Lisheng Pharmaceutical Co.,Ltd. (SZSE: 002393)
Health Care · Pharmaceuticals · CN
CN¥14.42
-3.22% today · -31.6% 1Y
Tianjin Lisheng Pharmaceutical Co.,Ltd. (SZSE: 002393) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $660.95M and employs 1,605 people.
Over the last twelve months the share price has lost 31.6%, trading between 13.37 and 21.59.
Tweenvest scores Tianjin Lisheng Pharmaceutical Co.,Ltd. across four factors: quality 73/100, value 69/100, growth 70/100, dividend 73/100. Its strongest factor is quality.
002393 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $660.95M
- Revenue (TTM)
- $191.69M
- P/E
- 29.52
- EPS
- 0.49
- Dividend yield
- 6.93%
- Beta (5Y)
- -0.07
- 52-week high
- CN¥21.59
- 52-week low
- CN¥13.37
- Avg volume (3M)
- —
- Shares outstanding
- 308.12M
- Employees
- 1,605
- Next earnings
- —
About Tianjin Lisheng Pharmaceutical Co.,Ltd.
Tianjin Lisheng Pharmaceutical Co.,Ltd. specializes in the manufacturing and distribution of chemical pharmaceutical products. Their extensive catalog features a variety of finished dosage forms, including tablets, hard capsules, dripping pills, freeze-dried powder injections, and water injections, alongside bulk medicines. The company also provides pharmaceutical intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. Headquartered in Tianjin, China, the firm extends its reach through product exports. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.
- ISIN
- CNE100000NJ9
- Founded
- 1951
- Listed since
- Apr 23, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,237.51 | -1.43% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.29 | +0.76% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.48 | -1.36% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.89 | -0.64% |
Figures last refreshed Aug 18, 2026.